Pinnbrook Capital Management LP Buys New Stake in Ralliant Corporation $RAL

Pinnbrook Capital Management LP bought a new stake in shares of Ralliant Corporation (NYSE:RAL) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 154,740 shares of the company’s stock, valued at approximately $7,878,000. Ralliant makes up approximately 1.1% of Pinnbrook Capital Management LP’s portfolio, making the stock its 26th largest position. Pinnbrook Capital Management LP owned 0.14% of Ralliant at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in Ralliant by 10.7% during the third quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock valued at $637,995,000 after acquiring an additional 1,415,327 shares in the last quarter. Viking Global Investors LP purchased a new position in Ralliant during the second quarter valued at $257,200,000. State Street Corp purchased a new position in Ralliant during the second quarter valued at $213,096,000. Flossbach Von Storch SE grew its stake in Ralliant by 1.7% during the third quarter. Flossbach Von Storch SE now owns 4,152,866 shares of the company’s stock valued at $181,605,000 after acquiring an additional 67,963 shares in the last quarter. Finally, Invesco Ltd. grew its stake in Ralliant by 90.1% during the third quarter. Invesco Ltd. now owns 3,871,690 shares of the company’s stock valued at $169,309,000 after acquiring an additional 1,835,128 shares in the last quarter.

Insider Activity at Ralliant

In related news, SVP Karen M. Bick sold 5,485 shares of Ralliant stock in a transaction dated Tuesday, March 3rd. The shares were sold at an average price of $45.00, for a total transaction of $246,825.00. Following the completion of the transaction, the senior vice president directly owned 46,756 shares of the company’s stock, valued at approximately $2,104,020. The trade was a 10.50% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Ralliant Price Performance

RAL stock opened at $59.92 on Friday. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $62.35. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.73. The company has a 50-day moving average price of $46.55 and a 200 day moving average price of $47.99. The stock has a market cap of $6.71 billion and a PE ratio of -5.48.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Tuesday, May 12th. The company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.08. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. The firm had revenue of $534.60 million during the quarter. The firm’s revenue was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. Equities research analysts anticipate that Ralliant Corporation will post 2.63 earnings per share for the current year.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 8th will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, June 8th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. Ralliant’s payout ratio is currently -1.83%.

Wall Street Analysts Forecast Growth

RAL has been the subject of a number of recent research reports. Vertical Research raised shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a research note on Friday, February 6th. Barclays lifted their price objective on shares of Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 13th. Morgan Stanley lifted their price objective on shares of Ralliant from $45.00 to $68.00 and gave the stock an “overweight” rating in a research note on Thursday, May 14th. Royal Bank Of Canada lifted their price objective on shares of Ralliant from $47.00 to $64.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 13th. Finally, Oppenheimer lifted their price objective on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Seven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $62.50.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.